PFGTF Stock - Pacific Edge Limited
Unlock GoAI Insights for PFGTF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $21.85M | $26.06M | $19.62M | $11.45M | $2.15M |
| Gross Profit | $21.85M | $13.48M | $9.60M | $4.56M | $-3,688,000 |
| Gross Margin | 100.0% | 51.7% | 49.0% | 39.9% | -171.4% |
| Operating Income | $-34,103,000 | $-45,917,000 | $-34,414,000 | $-22,186,000 | $-22,566,000 |
| Net Income | $-29,936,000 | $-29,535,000 | $-26,965,000 | $-19,788,000 | $-14,223,000 |
| Net Margin | -137.0% | -113.3% | -137.5% | -172.9% | -660.9% |
| EPS | $-0.04 | $-0.04 | $-0.03 | $-0.03 | $-0.02 |
Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore. It operates in two segments, Commercial and Research. The company offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer. It is also developing Cxbladder Resolve, a product that identifies those patients who are likely to have aggressive or more advanced bladder cancer; Cxbladder Triage, a product that identifies patients with haematuria who have a low probability of bladder cancer; Cxbladder Detect that enables the non-invasive detection of bladder and other urinary tract cancers; and Cxbladder Monitor, which allows urologists to monitor bladder cancer patients for recurrence of the disease. In addition, the company is developing Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancers; and products for bladder, gastric, colorectal, endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.
Visit WebsiteEarnings History & Surprises
PFGTFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 27, 2026 | — | — | — | — |
Q4 2025 | Nov 24, 2025 | — | $-0.01 | — | — |
Q2 2025 | May 29, 2025 | — | — | — | — |
Q4 2024 | Nov 25, 2024 | $-0.01 | $-0.01 | -5.8% | ✗ MISS |
Q2 2024 | May 20, 2024 | — | $-0.02 | — | — |
Q3 2023 | Sep 30, 2023 | $-0.01 | $-0.02 | -96.1% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | — | $-0.02 | — | — |
Q3 2022 | Sep 30, 2022 | $-0.07 | $-0.01 | +82.1% | ✓ BEAT |
Q1 2022 | Mar 31, 2022 | — | $-0.01 | — | — |
Q3 2021 | Sep 30, 2021 | $-0.01 | $-0.01 | -33.8% | ✗ MISS |
Q1 2021 | Mar 31, 2021 | — | $-0.01 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.01 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.01 | — | — |
Q4 2019 | Oct 1, 2019 | $-0.01 | $-0.01 | -48.6% | ✗ MISS |
Q1 2019 | Mar 31, 2019 | — | $-0.01 | — | — |
Q3 2018 | Sep 30, 2018 | — | $-0.01 | — | — |
Q1 2018 | Mar 31, 2018 | — | $-0.01 | — | — |
Q3 2017 | Sep 30, 2017 | — | $-0.01 | — | — |
Q1 2017 | Mar 31, 2017 | — | $-0.02 | — | — |
Q3 2016 | Sep 30, 2016 | — | $-0.02 | — | — |
Latest News
Frequently Asked Questions about PFGTF
What is PFGTF's current stock price?
What is the analyst price target for PFGTF?
What sector is Pacific Edge Limited in?
What is PFGTF's market cap?
Does PFGTF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to PFGTF for comparison